Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-002585-23Phase 4Completed
Phase 4, randomised, single-blind trial of furosemide (2 arms), sponsored by Medicinsk Forskningsafsnit, Regionshospitalet Holstebro. Primary endpoint: Urinary neutrophil gelatinase-associated lipocalin concentration. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-002585-23.